Ruxolitinib in Myelofibrosis and Polycythemia Vera

類似資料

• Overcoming treatment challenges in myelofibrosis and polycythemia vera: the role of ruxolitinib
  著者:: Bryan, Jeffrey C., 等
  出版事項: (2016)
• Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis
  著者:: Mikkelsen, Stine Ulrik, 等
  出版事項: (2018)
• Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis
  著者:: Stine Ulrik Mikkelsen, 等
  出版事項: (2018-08-01)
• Ruxolitinib for the Treatment of Patients With Polycythemia Vera
  著者:: Kiladjian, Jean-Jacques, 等
  出版事項: (2015)
• Tumor Lysis Syndrome after the Administration of Ruxolitinib in a Patient with Post-polycythemia Vera Myelofibrosis
  著者:: Koshiishi, Megumi, 等
  出版事項: (2017)